Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
217 Leser
Artikel bewerten:
(0)

Alfardan Group Moves Into the Health Sector With the Launch of 'Alfardan Medical With Northwestern Medicine'

DOHA, Qatar, January 26, 2019 /PRNewswire/ --

Alfardan Group has ventured into Qatar's medical services sector with the launch of Alfardan Medical with Northwestern Medicine (AMNM). Alfardan Group unveiled the new project at a press conference held at Northwestern University in Qatar, and attended by a representative of Qatar's Minister of Public Health, special guests and members of the media.

(Photo: https://mma.prnewswire.com/media/813712/Alfardan_Group.jpg )

(Photo: https://mma.prnewswire.com/media/813713/Alfardan_Medical.jpg )

Alfardan Medical with Northwestern Medicine (AMNM) will offer patients a wide variety of ambulatory care services later this year - a first-of-its-kind in Qatar. This is Alfardan Group's first investment in the health sector, as part of its social responsibility towards the State of Qatar and its vision to develop projects that will contribute to the realization of the Qatar National Vision.

Chicago-based Northwestern Medicine is one of the United States' premier academic health systems, anchored by Northwestern Memorial Hospital, one of the top ranked hospitals in the United States. The Northwestern Medicine health system is affiliated with Northwestern University Feinberg School of Medicine, ranked as one of the best research-oriented medical schools.

Mr. Omar Hussain Alfardan, President & CEO of Alfardan Group, said: "Alfardan Group has built its reputation on offering their clients a lifestyle in keeping with the quality, luxury, and premium services that they value. A sustained focus on meeting those needs and aspirations has seen the company reach tremendous heights of success in business."

Alfardan added: "With the opening of Alfardan Medical with Northwestern Medicine, our ambition is to enhance Qatar's medical system and reach global standards in healthcare. We are capable of delivering the most advanced integrated healthcare by leveraging our strengths in this venture, Northwestern Medicine, and their expertise in medical services, combined with the Alfardan Group's renowned capacity for service excellence. I am confident that these merits will truly differentiate Alfardan Medical with Northwestern Medicine as a premier healthcare provider."

Alfardan Group carried out a rigorous assessment of health care systems with the appropriate medical expertise and reputation prior to selecting Northwestern Medicine to provide the guidance, oversight and advice for both the construction and operation of the new Facility.

"Northwestern Medicine is committed to providing high-quality, compassionate care to patients that is informed by breakthrough research. We are pleased to have the opportunity to assist Alfardan Group in its new project to bring world-class care to Qatar," said Dean M. Harrison, President and Chief Executive Officer, Northwestern Memorial HealthCare. "With this collaboration with the Alfardan Group, we have the unique opportunity to extend our Patients First mission to the Qatari people."

AMNM will be located at Burj Alfardan in Lusail, and will occupy 11,000 sqm over six dedicated floors. The clinic's medical staff and clinicians will be a specialized team of multinational professionals including many from the U.S. The new and valuable addition to the private healthcare in Qatar will compliment Qatar's position in the field of medical tourism in the region.

Experienced, high-caliber physicians will provide the best levels of health care at the ambulatory care center in various medical specialties, including: ear, nose and throat (ENT), dentistry, dermatology, gastroenterology, internal medicine, ophthalmology, orthopedics, cosmetic and reconstructive surgery, reproductive endocrinology/embryology, physical medicine and rehabilitation (PM&R), sleep medicine and executive health.

Alfardan Group's entry into the medical sector marks the opening of a new chapter in the Group's success as one of Qatar's pioneering business leaders for over 60 years, which has seen the Group grow to become one of the premier family-owned conglomerates for several business lines in the region.

Alfardan Group continuously pursues growth opportunities that contribute to national interests and the Qatar National Vision to diversify the economy and promote sustainable development.

To learn more about Alfardan Group, visit alfardan.com.qa

To learn more about Northwestern Medicine, visit NM.org

About Alfardan Medical with Northwestern Medicine

Alfardan Medical with Northwestern Medicine (AMNM) is an ambulatory care center that provides high quality, multidisciplinary medical specializations, based in Burj Alfardan, Lusail.

AMNM is an international partnership between Alfardan Group and Northwestern Medicine (Chicago, U.S.A.). They each share a vision and a set of guiding values for the establishment, execution and operation of AMNM.

AMNM adopts an American patient-centric model, where the patient always comes first. The most advanced, innovative and patient-centric care from a multinational medical team, with significant U.S. representation, combines with service excellence at the state-of-the-art ambulatory care center and treatment facilities.

Specialties offered at AMNM include ear, nose and throat (ENT), dentistry, dermatology, gastroenterology, internal medicine, ophthalmology, orthopedics, cosmetic and reconstructive surgery, reproductive endocrinology/embryology, physical medicine and rehabilitation (PM&R), sleep medicine and executive health.

Introducing new medical specialties to the region enhances Qatar's position as a hub for premium medical services and medical tourism. AMNM patients will benefit from Alfardan Group's business offerings in a range of other sectors, to ensure seamless treatment arrangements.

For more information, please visit the AMNM website at http://www.amnm.com

© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.